Medical Devices & Pharma Articles
This week's top stories include Stryker's CEO change, Viatris' pain management deal, J&J's Q3 earnings and Flo and Google's femtech partnership
Roche’s $1.06bn obesity care deal could deliver “truly differentiated, next-generation therapy,” says Enza di Modungo, VP of Roche Pharma Partnering
CFO Joseph Wolk described Johnson & Johnson’s “diversified portfolio” as central to the company’s progress towards its record-breaking revenue target
Teva’s Weltruza was “developed with the patient in mind from day one,” says Chris Fox, Executive VP, as the company advances its “Pivot to Growth” strategy
Viatris CEO Scott Smith says the acquisition enables the firm to “strengthen our position in non-opioid pain management” and drive business growth
This week's top stories include J&J's menopause-eye health link, the UK's AI healthcare regulations, GE's HealthCare's CT technology and Bayer's Ohio site
Spencer Stiles, who will assume the CEO position after serving as COO at Stryker since January 2026, describes taking the role as a “tremendous privilege”
CEO Mike Mahoney names Joe Fitzgerald EVP & COO at Boston Scientific as the medtech giant restructures into three clinical segments